investor losses

TruBridge ($TBRG) disclosed material accounting errors across 2023-2025, triggering restatement and 10.5% stock decline. Securities litigation initiated.

DNOW stock crashed 19.1% after Q4 2025 earnings miss. The Rosen Law Firm investigates potential securities fraud; investors invited to join class action lawsuit.

ADMA Biologics stock plunged 16.6% after short seller allegations of channel stuffing. Law firm investigates potential securities fraud claims.

PennyMac Financial Services ($PFSI) faces securities investigation after servicing segment income crashed 76%, triggering 33% stock decline.

Immutep stock crashed 82.6% after discontinuing a Phase III trial; Rosen Law Firm investigating potential securities fraud claims for shareholders.

Sportradar faces securities investigation following Muddy Waters allegations of aiding illegal sportsbooks. Stock fell 22% after April report.

Rosen Law Firm investigates $SRAD following Muddy Waters report alleging illegal gambling ties. Stock plunged 22.6% on compliance concerns.

ImmunityBio faces class action securities fraud lawsuit over allegedly false Anktiva drug claims. Schall Law Firm recruiting investors who purchased stock January-March 2026.

The Gross Law Firm filed a securities class action against $GLOB for allegedly misrepresenting Latin American operations as stable while facing declining demand and wage freezes.

Schall Law Firm investigates Empro Group Inc. ($EMPG) for alleged securities violations, false statements, and material nondisclosure. Firm seeks affected shareholders for class-action participation.

GE HealthCare faces investor lawsuit after disclosing $250M in cost increases and slashing earnings guidance, triggering sharp stock decline.

Class action lawsuit filed against $MNDY for allegedly misleading investors about revenue outlook. Investors must act before May 11 lead plaintiff deadline.

Class action lawsuit filed against $GEMI alleging false statements on crypto platform viability and overstated expansion plans. Lead plaintiff deadline May 18, 2026.

Class action lawsuit filed against Regencell Bioscience for alleged false statements and failure to disclose DOJ investigation into trading practices.

Schall Law Firm files securities fraud class action against $ZSPC following December 2024 IPO, citing false disclosures and undisclosed preferred shareholder details.

Class action lawsuit alleges Stellantis made misleading statements about earnings growth and EV strategy, requiring significant charges to pivot away from battery-electric vehicles.

Securities class action alleges $BSX concealed unsustainable growth in electrophysiology segment, leading to earnings miss. Lead plaintiff deadline set for May 4, 2026.

Law firm Johnson Fistel investigates O-I Glass after earnings miss revealed European segment profit collapsed to near-zero, prompting 20% stock decline and guidance cuts.

Class action lawsuit filed against $GLOB alleges materially false statements regarding Latin America business challenges. Stock plummeted 27.8% in February 2025 after missed guidance.

Schall Law Firm investigates iTonic Holdings ($ITOC) for alleged securities fraud, including false statements and material disclosure failures. Harmed shareholders invited to participate.